MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/14712598.2024.2404079

Медицинская библиотека · Expert opinion on biological therapy · 2024

Mosunetuzumab for the treatment of follicular lymphoma.

Labanca Caterina, Martino Enrica Antonia, Vigna Ernesto, Bruzzese Antonella, Mendicino Francesco, De Luca Paola, Lucia Eugenio, Olivito Virginia, Fragliasso Valentina, Neri Antonino, Morabito Fortunato, Gentile Massimo

СтатьяОбзорПеревод в очереди

Аннотация

INTRODUCTION

Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma that shows a progressive increase in relapses and refractory in its natural history and a median survival of approximately 18-20 years. The advent of anti-CD20 monoclonal antibodies has changed the FL therapeutic algorithm, with an increase in progression-free survival. T-cell-dependent bispecific antibodies (BsAbs) represent an emerging drug class against FL.

AREAS COVERED: In this review, we selected papers from the principal databases (PubMed, Medline, Medscape, ASCO, ESMO) between January 2021 and June 2024, using the keywords 'mosunetuzumab' and 'follicular lymphoma' to provide an overview of mosunetuzumab-axgb, a pioneering BsAb. Its mechanism of action, efficacy, safety, and future perspectives were analyzed.

EXPERT OPINION: Mosunetuzumab grants a directing T-cell mediated cytotoxicity and allows a step-up dosing that reduces adverse events, such as cytokine release syndrome, with promising tolerability. At the same time, it improves outcomes in the evolving landscape of FL management, even in post-CAR-T FL patients. Prognostic factors and targetable mechanisms of resistance need to be explored.

Для цитирования: Labanca Caterina, Martino Enrica Antonia, Vigna Ernesto, Bruzzese Antonella, Mendicino Francesco, De Luca Paola, Lucia Eugenio, Olivito Virginia, Fragliasso Valentina, Neri Antonino, Morabito Fortunato, Gentile Massimo. Mosunetuzumab for the treatment of follicular lymphoma.. Expert opinion on biological therapy. 2024. DOI: 10.1080/14712598.2024.2404079.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.